1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Liquid Biopsy Market
2.2. Global Liquid Biopsy Market, By Analytes, 2023 (US$ Million)
2.3. Global Liquid Biopsy Market, By Application, 2023 (US$ Million)
2.4. Global Liquid Biopsy Market, By Geography, 2023 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2023

3. Liquid Biopsy Market: Competitive Analysis
3.1. Market Positioning of Key Liquid Biopsy Market Vendors
3.2. Strategies Adopted by Liquid Biopsy Market Vendors
3.3. Key Industry Strategies
4. Liquid Biopsy Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Liquid Biopsy Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Circulating Tumor Cells (CTCs)
5.3.2. Circulating Tumor DNA (ctDNA)
5.3.3. Extracellular Vesicles (EVs)

6. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Prognosis
6.3.2. Diagnosis
6.3.3. Therapy Monitoring
6.3.4. Others


7. North America Liquid Biopsy Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
7.3. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
7.4.Liquid Biopsy Market: By Region, 2022-2032, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
7.4.1.1.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
7.4.1.2.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
7.4.1.3.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)

8. UK and European Union Liquid Biopsy Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
8.3. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
8.4.Liquid Biopsy Market: By Region, 2022-2032, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
8.4.1.1.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
8.4.1.2.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
8.4.1.3.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
8.4.1.4.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
8.4.1.5. France
8.4.1.5.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
8.4.1.5.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
8.4.1.6.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)

9. Asia Pacific Liquid Biopsy Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
9.3. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
9.4.Liquid Biopsy Market: By Region, 2022-2032, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
9.4.1.1.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
9.4.1.2.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
9.4.1.3. India
9.4.1.3.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
9.4.1.3.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
9.4.1.4.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
9.4.1.5.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
9.4.1.6.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)

10. Latin America Liquid Biopsy Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
10.3. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
10.4.Liquid Biopsy Market: By Region, 2022-2032, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
10.4.1.1.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
10.4.1.2.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
10.4.1.3.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)

11. Middle East and Africa Liquid Biopsy Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
11.3. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
11.4.Liquid Biopsy Market: By Region, 2022-2032, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
11.4.1.1.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
11.4.1.2.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Liquid Biopsy Market: By Analytes, 2022-2032, USD (Million)
11.4.1.3.2. Liquid Biopsy Market: By Application, 2022-2032, USD (Million)

12. Company Profile
12.1. Myriad Genetics
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Oncocyte
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. RainDance Technologies
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Veracyte
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Foundation Medicine
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. Genomic Health
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. Biocept
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Natera
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Qiagen
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Trovagene
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. Others
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives